Literature DB >> 31327258

Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.

Hiroki Kobayashi1,2,3, Masanori Abe1, Yoshihiro Nakamura1, Katsutoshi Takahashi4,5, Megumi Fujita5, Yoshiyu Takeda6, Takashi Yoneda6, Isao Kurihara7, Hiroshi Itoh7, Mika Tsuiki8, Norio Wada9, Takamasa Ichijo10, Takuyuki Katabami11, Yoshihiro Ogawa12, Junji Kawashima13, Takanobu Yoshimoto12, Masakatsu Sone14, Nobuya Inagaki14, Minemori Watanabe15, Kohei Kamemura16, Yuichi Matsuda17, Shoichiro Izawa18, Makito Tanabe19, Akiyo Tanabe20, Tomoko Suzuki21, Mitsuhide Naruse8.   

Abstract

Primary aldosteronism causes renal structural damage after glomerular hyperfiltration, and primary aldosteronism-specific treatment leads to an acute fall in estimated glomerular filtration rate (eGFR). We investigated whether this change affected the long-term eGFR slope in a retrospective cohort from the multicenter Japan Primary Aldosteronism Study. We allocated patients with primary aldosteronism to the adrenalectomy (n=202) and MR (mineralocorticoid receptor) antagonist (n=303) groups based on their treatment history and analyzed the association between the initial eGFR fall and long-term eGFR slope. The increased age, low serum potassium levels, high eGFR, and high plasma aldosterone levels were independent predictors for a large initial eGFR fall in both groups. Our analysis of tertiles based on the initial eGFR fall revealed that in the MR antagonist group, patients with a small initial eGFR fall had a significantly steeper long-term eGFR slope than those with a large initial fall (tertile 1 versus 2, P=0.025; tertile 1 versus 3, P=0.017). These associations were not identified in the adrenalectomy group. Thus, the smaller the acute fall in eGFR by initiation of MR antagonists, the greater was the rate of long-term eGFR decline. While the acute fall in eGFR induced by primary aldosteronism-specific treatment is occasionally a clinical concern, our findings highlight the favorable implications of the acute fall with respect to long-term renal outcomes.

Entities:  

Keywords:  adrenalectomy; aldosterone; glomerular filtration rate; hyperaldosteronism; kidney

Mesh:

Substances:

Year:  2019        PMID: 31327258     DOI: 10.1161/HYPERTENSIONAHA.119.13131

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism.

Authors:  Yusuke Kobayashi; Tatsuya Haze; Yuichiro Yano; Kouichi Tamura; Isao Kurihara; Takamasa Ichijo; Takashi Yoneda; Takuyuki Katabami; Mika Tsuiki; Norio Wada; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Tetsuya Yamada; Ryuji Okamoto; Megumi Fujita; Kohei Kamemura; Koichi Yamamoto; Shoichiro Izawa; Akiyo Tanabe; Mitsuhide Naruse
Journal:  Kidney Int Rep       Date:  2020-06-20

2.  Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.

Authors:  Yuta Tezuka; Adina F Turcu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-26       Impact factor: 5.555

3.  The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study.

Authors:  Josephine Matzen; Lise Sofie Bislev; Tanja Sikjær; Lars Rolighed; Mette Friberg Hitz; Pia Eiken; Anne Pernille Hermann; Jens-Erik Beck Jensen; Bo Abrahamsen; Lars Rejnmark
Journal:  BMC Endocr Disord       Date:  2022-01-06       Impact factor: 2.763

Review 4.  A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics.

Authors:  Giovanna Capolongo; Giovambattista Capasso; Davide Viggiano
Journal:  Int J Mol Sci       Date:  2022-04-01       Impact factor: 5.923

Review 5.  Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism.

Authors:  Sumaiya Ahmed; Gregory L Hundemer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-26       Impact factor: 6.055

6.  Is acute kidney injury after laparoscopic adrenalectomy related to the progression of chronic kidney disease in patients with primary aldosteronism?

Authors:  Jee Hee Yoon; Ho Seok Chung; A Ram Hong; Hee Kyung Kim; Ho-Cheol Kang; Myung Soo Kim; Eu Chang Hwang; Seung Il Jung; Kwangsung Park; Dongdeuk Kwon
Journal:  Investig Clin Urol       Date:  2021-07-22

7.  Developing a research database of primary aldosteronism: rationale and baseline characteristics.

Authors:  Wen Wang; Yuanmei Li; Qianrui Li; Tingting Zhang; Wei Wang; Dan Mo; Haoming Tian; Tao Chen; Yan Ren
Journal:  BMC Endocr Disord       Date:  2021-06-29       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.